Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Multiple LY900014 Formulations

NCT02636361 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02636361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02636361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics, Glucodynamics, Safety, and Tolerability of Multiple LY900014 Formulations
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2015
Completion date
February 29, 2016
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy